Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sea Limited
SE
|
+$1.03B |
| 2 |
Coupang
CPNG
|
+$978M |
| 3 |
Roblox
RBLX
|
+$473M |
| 4 |
Analog Devices
ADI
|
+$303M |
| 5 |
Ginkgo Bioworks
DNA
|
+$284M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$921M |
| 2 |
Alibaba
BABA
|
+$476M |
| 3 |
Petrobras
PBR
|
+$417M |
| 4 |
Zillow
Z
|
+$416M |
| 5 |
NVIDIA
NVDA
|
+$348M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 28.15% |
| 2 | Healthcare | 23.85% |
| 3 | Technology | 18.9% |
| 4 | Communication Services | 11.36% |
| 5 | Financials | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BZUN
226
Baozun
BZUN
$172M
| $12.7M | 0.01% |
1,479,159
-45,773
| -3% | -$506K |
|
|
BNFT
227
DELISTED
Benefitfocus, Inc.
BNFT
| $12.5M | 0.01% |
993,007
-20,168
| -2% | -$215K |
|
228
Visa
V
$677B
| $11.6M | 0.01% |
52,499
| – | – |
|
229
Bumble
BMBL
$373M
| $11.6M | 0.01% |
400,000
| – | – |
|
230
Health Catalyst
HCAT
$128M
| $11.5M | 0.01% |
440,167
+41,788
| +10% | +$1.19M |
|
231
American Superconductor
AMSC
$1.59B
| $11.3M | 0.01% |
1,491,370
| – | – |
|
232
Ascendis Pharma A/S
ASND
$16.8B
| $11.1M | 0.01% |
94,651
+8,579
| +10% | +$994K |
|
233
Sherwin-Williams
SHW
$89.8B
| $11.1M | 0.01% |
44,453
| – | – |
|
234
Verisk Analytics
VRSK
$25B
| $10.8M | 0.01% |
50,495
| – | – |
|
235
Align Technology
ALGN
$12.3B
| $10.7M | 0.01% |
24,631
| – | – |
|
236
Butterfly Network
BFLY
$2.35B
| $10.5M | 0.01% |
2,215,630
+142,092
| +7% | +$780K |
|
|
NBTX
237
Nanobiotix
NBTX
$1.94B
| $10.5M | 0.01% |
1,400,000
| – | – |
|
|
HUYA
238
Huya Inc
HUYA
$558M
| $9.54M | 0.01% |
2,133,740
-5,519,408
| -72% | -$31.7M |
|
239
Veeva Systems
VEEV
$37.4B
| $9.49M | 0.01% |
44,655
+4,442
| +11% | +$964K |
|
240
Smartbird Inc
BIRD
$22.3M
| $8.22M | 0.01% |
68,404
+41,779
| +157% | +$8.22M |
|
|
ZY
241
DELISTED
Zymergen Inc. Common Stock
ZY
| $8.15M | 0.01% |
2,821,956
| – | – |
|
|
API
242
Agora
API
$377M
| $7.4M | 0.01% |
744,300
| – | – |
|
243
Relay Therapeutics
RLAY
$4.33B
| $7.31M | 0.01% |
244,277
+19,236
| +9% | +$467K |
|
|
DCBO
244
Docebo
DCBO
$566M
| $7.23M | 0.01% |
139,764
+71
| +0.1% | +$3.65K |
|
245
HUTCHMED
HCM
$2.17B
| $6.92M | ﹤0.01% |
365,792
+1,724
| +0.5% | +$43.9K |
|
246
TJX Companies
TJX
$178B
| $6.51M | ﹤0.01% |
107,431
+20,538
| +24% | +$1.38M |
|
247
Fortive
FTV
$18.6B
| $5.96M | ﹤0.01% |
129,799
| – | – |
|
|
YSG
248
Yatsen Holding
YSG
$319M
| $5.66M | ﹤0.01% |
1,648,417
-3,514
| -0.2% | -$23.5K |
|
249
Alector
ALEC
$199M
| $5.59M | ﹤0.01% |
392,351
+32,627
| +9% | +$516K |
|
250
BridgeBio Pharma
BBIO
$16.5B
| $5.5M | ﹤0.01% |
541,891
+52,170
| +11% | +$535K |
|
Similar funds
Baillie Gifford & Co's Q1 2022 Portfolio in Review
As of Q1 2022, Baillie Gifford & Co held 510 positions worth $143B, down 22% from $182B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 4.5%. Baillie Gifford & Co opened 11 new positions and exited 12, leaving the 510-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.
- Baillie Gifford & Co's largest Q1 2022 buy was Roblox: 7,841,669 shares worth $363M.
- Baillie Gifford & Co added most to Sea Limited in Q1 2022, an estimated $1.03B increase.
- Baillie Gifford & Co's biggest Q1 2022 reduction was Tesla, cutting an estimated $921M.
- Baillie Gifford & Co fully exited Stericycle Inc in Q1 2022, selling an estimated $283M.
- Baillie Gifford & Co's ten largest holdings make up 40% of its $143B portfolio in Q1 2022.
- Baillie Gifford & Co opened 11 new positions and closed 12 in Q1 2022.
- Baillie Gifford & Co's portfolio value fell 22% quarter-over-quarter to $143B.
Based on Baillie Gifford & Co's 13F filing for Q1 2022, filed 5 May 2022.